ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

OPTI Optibiotix Health Plc

18.125
0.00 (0.00%)
22 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Optibiotix Health Plc LSE:OPTI London Ordinary Share GB00BP0RTP38 ORD 2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 18.125 17.75 18.50 18.125 18.125 18.13 75,129 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Noncomml Resh Organizations 457k 2.59M 0.0284 6.38 16.52M
Optibiotix Health Plc is listed in the Noncomml Resh Organizations sector of the London Stock Exchange with ticker OPTI. The last closing price for Optibiotix Health was 18.13p. Over the last year, Optibiotix Health shares have traded in a share price range of 5.75p to 43.50p.

Optibiotix Health currently has 91,190,661 shares in issue. The market capitalisation of Optibiotix Health is £16.52 million. Optibiotix Health has a price to earnings ratio (PE ratio) of 6.38.

Optibiotix Health Share Discussion Threads

Showing 20626 to 20648 of 147650 messages
Chat Pages: Latest  830  829  828  827  826  825  824  823  822  821  820  819  Older
DateSubjectAuthorDiscuss
09/2/2017
16:35
Just out of interest, when I read the main thread, most of the shareholders appear to be overweight and/or have high blood pressure or high cholesterol.

Just a thought but if Opti did eventually come good would any of you still be alive to spend your ill gotten gains? ;)

P.S. Out of interest I tried a Go-Figure shake. If it helps anybody, I didn't like the taste so I added a soup starter, steak and chips for main, a crème Brulee dessert and washed it down with a pint of Boddingtons. I think the shake must have worked because I went for at least two hours without feeling hungry again. In fact for supper I just had a shake and a cheese and pickle sandwich. Oh and a packet of crisps, and then some pork scratchings.......... Didn't have to get up in the night once for a midnight feast. Marvellous those shakes.

Actually that last paragraph isn't entirely true. It was two packets of crisps ;)

michaelmouse
09/2/2017
16:17
riskybusiness1 - "maybe the mouse on the other thread will live to regret putting more time and effort in to writing rubbish than doing proper research."

If you think I write rubbish then that's your prerogative.

We clearly beg to differ. I have no issue with the company and indeed wish them well in their endeavours.

However, the company is already valued in the multi-millions and has recorded at the half-year just £88,000 in revenues. Despite your so-called research the fact remains that the business model is not yet proven and meaningful revenues and profits are a considerable way off.

Therein lies the considerable risk at the current valuation. There is no room for error and no margin of safety.

If I'm wrong then I can live with that. IMV the risk/reward is massively skewed towards risk rather than reward.

There are always plenty of opportunities out there with better odds imo.

michaelmouse
09/2/2017
16:05
Well, haven't had to take advantage of the Go Figure range as not overweight, but I do have raised cholesterol and high blood pressure..... so as soon as I can get my hands on a pack of this stuff the better!!
I would enjoy better health, less likely to have heart attack, and therefore live longer so as to enjoy the huge future dividends Im sure owning many thousands of Opti shares will produce!! Win , Win.! ( is that train of thought realistic? Hope so)

nicktopten
09/2/2017
15:53
Good post risky.
someuwin
09/2/2017
15:41
This is only one product in one platform. Interesting the presentation mentions that the next group to study will be the higher cholesterol group which had a 26% reduction. Replicate this with 100+ people and this product will be big whoever the partner. The latter part of the presentation showed the 3x extra increase in the cholesterol reduction when the lpgos from the optibiotic platform was added to the probiotic. Shows the value overlap between the platforms very clearly. Clear example of how opti can use this tech to improve probiotics health benefits - dsm £10bn+ mkt cap worlds biggest ingredient supplier using AND PAYING FOR (six figure sum) the privilege to use Optis tech to enhance their products whilst opti retains a future 7-15% license revenue and royalties. How many other companies with established sales will want to enhance their products in an market transitioning from general well bring to a focus on specific health benefits. Chr hannsens purchasing of Valios single strain for £60m shows the market leaders moving in for proven specific health benefits. This accumulation of data by opti is the start of such process. What happens if these next generation Synbiotics are used in clinicals within a high cholesterol test group (The probiotic alone showed a 26% reduction in this group). Taking in to account the lpgos has a 3x increase in the probiotics ability to reduce cholesterol..... maybe the mouse on the other thread will live to regret putting more time and effort in to writing rubbish than doing proper research.Time will tell.
riskybusiness1
09/2/2017
15:09
Here are the posters from Probiota:
parob
09/2/2017
14:13
Yes, impressive results in the presentation. As the wider science based companies see what OPTI has, it is no wonder SOH has been so busy. Being on a number of different tablets already means I am reluctant to add more. However, a simple additive to food or similar supplement I would be very willing to consume.
rafboy
09/2/2017
13:49
Another great presentation by SOH. Said he had a dozen people from a large range of companies waiting to speak to him afterwards who were "interested in distributing and marketing our products".Most of the reduction in total and bad cholesterol was within 6 weeks - so pretty fast results!
parob
09/2/2017
13:26
Highly likely imo neft
someuwin
09/2/2017
13:05
Thanks someuwin for posting the presentation link. He says and i can quite understand that it is a very costly business to involve actual human studies, a number of 49 taking part was mentioned. Partners to sponsor further human study testing. The results in lowering BAD cholesterol and blood pressure and increasing GOOD cholesterol are impressive. I just wonder if good old P & G have been funding their own human study testing all these months.
neftanikoff
09/2/2017
12:42
SOH does a great job of explaining the presentation slides there.

Has been submitted to the British Journal of Nutrition for peer review.

All set for spring launch of cardiovascular products.

But clearly talk of next generation pipeline suggests much more to come further down the line.

someuwin
09/2/2017
12:11
Not much mileage there Somuwin, would you say? Nor in the bullish PSL write-up/tip. Bring on something meaty?
owenmo
09/2/2017
12:01
PRESENTATION: Opibiotix Health Plc at ProBiota, Berlin Feb 2017

OptiBiotix Health plc (LON:OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol, diabetes and skin care, announced in January that it has had two abstracts accepted for presentation at ProBiota 2017 in Berlin from 1-3 February 2017. ProBiota is the leading annual event for the global prebiotic, probiotic and the microbiota focused food and pharma industries. The conference is world renowned as a key meeting place for a community of scientists and business leaders who want to translate science into new products in the growing supplements and ingredients market.

CEO Stephen O’Hara talks through the presentation on LP-LDL®: Cholesterol & hypertension reduction – Next generation pre, pro, and synbiotics that he gave at a conference in Berlin on the 3rd Feb 2017 attended by over 250 scientists from around the world...

someuwin
09/2/2017
11:30
Nef just SOHs brother,are you sure you own shares :)) ? or are you one of these posters who "keeps his feet on the ground" yawn yawn.
scotty1
09/2/2017
11:25
Lets hope P&G give approval for it to be announced in an RNS and not an interview.

I guess probably not

onedayrodders
09/2/2017
11:23
re 19754omg, jeeeezzzz, scotty you are not bringing up TW yet again, don't forget he is the creator of the soh's brother's/son/auntie/uncle/grannies got shares in opti along with for the 100th time, get in before 80, it's going 100 plus, first said about a year ago, yawn, yawn.
neftanikoff
09/2/2017
11:21
Good observation - Someuwin. I don't think many doubted the veracity just the "imminent" delivery of the P&G news, which by all accounts is 12 months late, 16 months by Easter. I would have expected AR had a better understanding how these type of deals with MN playout before he gave TW the wink.
elrico
09/2/2017
11:17
someuwin - i was thinking the same thing. I believe is was TW who confidently said the Asian MN was TATA and its proved correct. Whether this was orchestrated by Opti I don't know; however, for those that say TW talks boll*x, he was 100% this time. So, if it was also TW who started the P&G rumour, it has considerable credence.

Still can't get my head around TATA news not being RNSed. With the news being dripped out via a minor news blog there has been zero impact on share price I would have thought that an agreement with a big MN such as Tata was market sensitive and so there was an obligation to RNS - but WTFDIK.

kipper1960
09/2/2017
10:34
Now that the TATA 'rumour' has been confirmed as true, it give more credence to the other 'rumour' that Procter & Gamble is the first multinational. After all they both came from the same source.
someuwin
09/2/2017
10:26
Just means it was poorly packed - if it reduces cholesterol who gives a fig.
elrico
09/2/2017
10:26
Nef, you seem to be eyeing other shares recent rises jealously. Do you not think they did the same a year or so ago when Opti went from 10p to £1? OXP crashed from 13p so it's only in early recovery mode. Do you really think it's a better bet than Opti as I don't. You do sound like someone who only bought in here around current levels for a quick buck ..if not, why so anxious to see immediate gains. I watched Opti for over a year before I felt comfortable enough in its progress to take my position a few months ago at 65p.
portrush
09/2/2017
10:24
That cash position has been bugging me a little, but of course a large part of the answer lies here.



"Under the terms of the agreement, OptiBiotix has increased its investment into SkinBiotix, using a Convertible Loan Agreement, with an investment of £400k which will provide funding to complete the development and human studies for the first product application, in addition to funding activities to support an Initial Public Offering ("IPO").  The loan will convert should SkinBiotix successfully complete and IPO."

That's it. They've used toxic debt as possible funding for a possible IPO of SkinBiotix (although that's all gone very quiet I note). In other words the £400,000 investment will be debt on the balance sheet rather than a cash deduction, at this juncture anyway.

It raises the following though. If the IPO doesn't go ahead then that £400,000 will come directly from cash resources. So £2.8m cash left which is getting close to my estimate. If the IPO does go ahead then what's the coupon on the debt? Normally quite high, and what will the conversion price be? Normally a hefty discount to the prevailing share price As ever there is very little detail about the terms.

In summary, they owe £400,000 in debt.

Looking forward to the results.

michaelmouse
09/2/2017
10:21
Does the bouncing pill gives the same effect as uppers and downers?
asterix96
Chat Pages: Latest  830  829  828  827  826  825  824  823  822  821  820  819  Older